Home games nearly double the crowd: World Cup WiFi data shows what the quarter final is worth to UK pubs, so Purple is dressing their WiFi in the England flag for free Fujitsu’s Digital Annealer achieves excellent results in the Kutxabank project of requesting assets from its investment portfolios
TOKYO, Dec 22, 2022 – (JCN Newswire) – Fujitsu’s quantum-inspired solution, Digital Annealer, has achieved…
ADS-TEC Energy Establishes First North American Site for Its Ultra-Fast Charging Technology in Auburn, Alabama
ADS-TEC Energy to invest $8 million dollars in sales, warehousing, service and assembly facility, creating…
Black & Veatch to Deliver Seawater Desalination Plant in Indonesia Saving Precious Fresh Water Resources at World’s Largest Designed Single Line Copper Smelter
The plant will produce over 1,400 cubic meter per hour (m3/hr) of desalinated seawater to…
Spruce Power Announces Changes to its Board of Directors
–Deb Frodl and Sarah Sclarsic Transition off Board Effective December 31, 2022– –Chris Hayes Elected…
Enjoy Tai Chi and Health Together – The Series of Activities for the Second Anniversary Making the Inscription of Taijiquan on the UNESCO Representative List of Intangible Cultural Heritage of Humanity Was Officially Launched
Wenxian, China–(Newsfile Corp. – December 21, 2022) – On December 17, 2022, under the guidance…
LanzaTech’s Waste Gas-to-SAF Facility receives £25M Grant from UK Department for Transport Advanced Fuels Fund
World’s first commercial-scale facility to convert waste gases into sustainable aviation fuel expected to produce…
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer
ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study…
Press Release: Positive Dupixent® (dupilumab) Phase 3 results in adults and adolescents with eosinophilic esophagitis published in the New England Journal of Medicine
Positive Dupixent®(dupilumab) Phase 3 results in adults and adolescents with eosinophilic esophagitis published in the…
Avicanna Announces Promotion of Phillip Cardella to Chief Financial Officer and Closing of Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant…
Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders
Company Intends to Hold FY 2022 Annual Meeting in February 2023 NEW YORK, Dec. 21,…
Lexicon Announces Topline Results From Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia
LX9211.202 ADPS Results: Separation from Placebo Was Seen by Week 1 in LX9211 Treatment Arm…
Eagle Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
WOODCLIFF LAKE, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
$259 Million in Equity Securities Sales and $50 Million in Additional Debt Financing Capacity Madrigal…
NANOBIOTIX Announces Termination of Liquidity Contract and Publishes End of Contract Statement
PARIS and CAMBRIDGE, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ:…
Cognition Therapeutics Announces Participation in Sachs 6th Annual Neuroscience Forum, Biotech Showcase, and BIO Partnering @ JPM During “J.P. Morgan Week 2023”
PURCHASE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company”…
C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
Eledon to Incorporate the iBox Scoring System in Future Kidney Transplant Trials IRVINE, Calif., Dec….
Akero Therapeutics Completes Enrollment of Phase 2b SYMMETRY Study and Announces Expected 2023 Milestones
Results of the main study in patients with compensated cirrhosis due to NASH (F4) expected…
FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults
Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the…
Synchronoss Announces More Than 30 Million RCS-Based Messaging Subscribers in Japan
Leveraging the Synchronoss Advanced Messaging Platform, NTT DOCOMO, KDDI, and SoftBank Deliver Cross-Operator Advanced Messaging…